OMERS ADMINISTRATION Corp Purchases Shares of 121,800 ASP Isotopes Inc. $ASPI

OMERS ADMINISTRATION Corp bought a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 121,800 shares of the company’s stock, valued at approximately $896,000. OMERS ADMINISTRATION Corp owned about 0.15% of ASP Isotopes as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. AWM Investment Company Inc. increased its position in shares of ASP Isotopes by 6.2% during the first quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company’s stock worth $21,157,000 after purchasing an additional 265,000 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC grew its stake in ASP Isotopes by 11.2% during the 1st quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company’s stock worth $16,453,000 after buying an additional 354,517 shares during the last quarter. Rovida Investment Management Ltd increased its position in ASP Isotopes by 528.6% during the 2nd quarter. Rovida Investment Management Ltd now owns 2,200,000 shares of the company’s stock valued at $16,148,000 after buying an additional 1,850,000 shares in the last quarter. Rovida Advisors Inc. acquired a new position in ASP Isotopes during the 2nd quarter valued at about $16,148,000. Finally, Geode Capital Management LLC raised its stake in ASP Isotopes by 7.6% in the second quarter. Geode Capital Management LLC now owns 1,348,072 shares of the company’s stock valued at $9,924,000 after buying an additional 94,751 shares during the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ASPI has been the topic of a number of research analyst reports. Loop Capital set a $15.00 price target on ASP Isotopes in a research note on Monday, October 27th. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research note on Monday, November 24th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, ASP Isotopes currently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Up 2.7%

ASP Isotopes stock opened at $5.73 on Thursday. The business’s 50-day simple moving average is $8.85 and its two-hundred day simple moving average is $8.78. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The company has a market cap of $635.11 million, a PE ratio of -4.41 and a beta of 3.41. ASP Isotopes Inc. has a fifty-two week low of $3.65 and a fifty-two week high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The firm had revenue of $4.89 million for the quarter, compared to analyst estimates of $2.25 million. Equities analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Buying and Selling at ASP Isotopes

In related news, Chairman Paul Elliot Mann sold 162,153 shares of the firm’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the transaction, the chairman owned 7,759,538 shares of the company’s stock, valued at $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $5.77, for a total transaction of $144,250.00. Following the transaction, the chief executive officer owned 1,554,693 shares of the company’s stock, valued at $8,970,578.61. This represents a 1.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 748,352 shares of company stock valued at $5,739,906. 21.40% of the stock is currently owned by insiders.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.